z-logo
open-access-imgOpen Access
Parkinson's disease, sleepiness and hypocretin/orexin
Author(s) -
Christian R. Baumann,
Thomas E. Scammell,
Claudio L. Bassetti
Publication year - 2007
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awm220
Subject(s) - narcolepsy , parkinson's disease , orexin , medicine , neuroscience , excessive daytime sleepiness , disease , psychology , psychiatry , neurology , sleep disorder , neuropeptide , insomnia , receptor
Sir, Sleepiness and disrupted sleep substantially impair quality of life in people with Parkinson's disease (PD) (Arnulf et al. , 2000). The hypocretin/orexin neuropeptides stabilize wakefulness and sleep, and in two recent studies, Fronczek et al. (2007) and Thannickal et al. (2007) showed that patients with late-stage PD have a 38–45% loss of the hypothalamic hypocretin-producing neurons. These studies provide novel and important insights into the neuropathology of PD, but several questions remain about whether this partial loss of hypocretin neurons actually causes the sleep–wake disturbances of PD.First, are the sleep-related symptoms of PD consistent with a loss of hypocretin neurons? Narcolepsy is caused by a 90–95% loss of the hypocretin neurons and is characterized by excessive daytime sleepiness and cataplexy (sudden loss …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom